Telo Genomics: Kris Weinberg

Kris Weinberg has been appointed as CEO of Telo Genomics, replacing Sherif Louis, who will become the Toronto-based telomere analysis company's president and chief technology officer. Weinberg most recently led commercial activities at Theralink Technologies. Previously, he held commercial leadership roles at Natera, Guardant Health, Biodesix, and Genomic Health.